Evidence map›Paper›PMID 39636636›Full record

ArticleJAMA network open2024

Predictors of Death or Severe Impairment in Neonates With Hypoxic-Ischemic Encephalopathy.

Hannah C Glass, Thomas R Wood, Bryan A Comstock, Adam L Numis, Sonia L Bonifacio, Marie-Coralie Cornet, Fernando F Gonzalez, Adriana Morell, Sarah E Kolnik, Yi Li and 8 more

Erratum issuedAbstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Development of a prediction model for mortality in infants undergoing therapeutic hypothermia for neonatal encephalopathy.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Error in Table 1.JAMA network open · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Hannah C GlassDepartment of Neurology, Weill Institute for Neuroscience, University of California, San Francisco.
Thomas R WoodDepartment of Pediatrics, Division of Neonatology, University of Washington School of Medicine, Seattle Children's Hospital, Seattle.
Bryan A ComstockDepartment Biostatistics, University of Washington, Seattle.
Adam L NumisDepartment of Neurology, Weill Institute for Neuroscience, University of California, San Francisco.
Sonia L BonifacioDepartment of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University, Palo Alto, California.
Marie-Coralie CornetDepartment of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco.
Fernando F GonzalezDepartment of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco.
Adriana MorellDepartment of Neurology, Weill Institute for Neuroscience, University of California, San Francisco.
Sarah E KolnikDepartment of Pediatrics, Division of Neonatology, University of Washington School of Medicine, Seattle Children's Hospital, Seattle.
Yi LiDepartment of Radiology and Biomedical Imaging, University of California, San Francisco.
Amit MathurDepartment of Pediatrics, St Louis University School of Medicine, St Louis, Missouri.
Ulrike MietzschDepartment of Pediatrics, Division of Neonatology, University of Washington School of Medicine, Seattle Children's Hospital, Seattle.
Tai-Wei WuFetal and Neonatal Institute, Children's Hospital Los Angeles, Keck School of Medicine of USC, Los Angeles, California.
Courtney J WusthoffDepartment of Neurology, Stanford University, Palo Alto, California.
Marianne ThoresenNeonatal Neuroscience, Translational Health Sciences, University of Bristol, Bristol, United Kingdom.
Patrick J HeagertyDepartment Biostatistics, University of Washington, Seattle.
Sandra E JuulDepartment of Pediatrics, Division of Neonatology, University of Washington School of Medicine, Seattle Children's Hospital, Seattle.
Yvonne W WuDepartment of Neurology, Weill Institute for Neuroscience, University of California, San Francisco.

Funding

High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCCU01NS092764 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JUUL, SANDRA E, WU, YVONNE W · 2016 to 2020
$12.7M
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) DCCU01NS092553 · NINDS · UNIVERSITY OF WASHINGTON · PI HEAGERTY, PATRICK J · 2016 to 2020
$1.7M
HEAL - EEG - Neurophysiologic measures of Epo treatment for hypoxic-ischemic encephalopathy (HIE)R01NS104322 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLASS, HANNAH CRANLEY · 2018 to 2021
$1.5M
NINDS NIH HHS R01 NS104322NINDS NIH HHS U01 NS092553NINDS NIH HHS U01 NS092764
6 · The paper itself

Abstract

Importance: Outcomes after hypoxic-ischemic encephalopathy (HIE) are variable. Predicting death or severe neurodevelopmental impairment (NDI) in affected neonates is crucial for guiding management and parent communication. Objective: To predict death or severe NDI in neonates who receive hypothermia for HIE. Design, Setting, and Participants: This prognostic study included participants enrolled in a large US clinical trial conducted in US neonatal intensive care units who were born between January 2017 and October 2019 and followed up to age 2 years. Eligible participants were neonates with moderate-severe HIE born at 36 weeks or more gestation and with 2-year outcome data. Data were analyzed June 2023. External validation was performed with a UK cohort. Exposure: Clinical, electroencephalography (EEG), and magnetic resonance imaging (MRI) variables were curated and examined at 24 hours and following cooling. Main Outcome and Measures: Death or severe NDI at age 2 years. Severe NDI was defined as Bayley Scales of Infant Toddler Development cognitive score below 70, Gross Motor Function Classification System score of 3 or higher, or quadriparesis. Model performance metrics were derived from training, internal, and external validation datasets. Results: Among 424 neonates (mean [SD] gestational age, 39.1 [1.4] weeks; 192 female [45.3%]; 28 Asian [6.6%], 50 Black [11.8%], 311 White [73.3%]), 105 (24.7%) had severe encephalopathy at enrollment. Overall, 59 (13.9%) died and 46 (10.8%) had severe NDI. In the 24-hour model, the combined presence of 3 clinical characteristics-(1) severely abnormal EEG, (2) pH level of 7.11 or below, and (3) 5-minute Apgar score of 0-had a specificity of 99.6% (95% CI, 97.5%-100%) and a positive predictive value (PPV) of 95.2% (95% CI, 73.2%-99.3%). Validation model metrics were 97.9% (95% CI, 92.7%-99.8%) for internal specificity, with a PPV of 77.8% (95% CI, 43.4%-94.1%), and 97.6% (95% CI, 95.1%-99.0%) for external specificity, with a PPV of 46.2% (95% CI, 23.3%-70.8%). In the postcooling model, specificity for T1, T2, or diffusion-weighted imaging (DWI) abnormality in at least 2 of 3 deep gray regions (ie, thalamus, caudate, putamen and/or globus pallidus) plus a severely abnormal EEG within the first 24 hours was 99.1% (95% CI, 96.8%-99.9%), with a PPV of 91.7% (95% CI, 72.8%-97.8%). Internal specificity in this model was 98.9% (95% CI, 94.1%-100%), with a PPV of 92.9% (95% CI, 64.2%-99.0%); external specificity was 98.6% (95% CI, 96.5%-99.6%), with a PPV of 83.3% (95% CI, 64.1%-93.4%). Conclusions and Relevance: In this prognostic study of neonates with moderate or severe HIE who were treated with therapeutic hypothermia, simple models using readily available clinical, EEG, and MRI results during the hospital admission had high specificity and PPV for death or severe NDI at age 2 years.

Indexed as

ElectroencephalographyHypothermia, InducedHypoxia-Ischemia, BrainChild, PreschoolFemaleHumansInfantInfant, NewbornMagnetic Resonance ImagingMaleNeurodevelopmental DisordersPrognosisSeverity of Illness Index

Identifiers

PMID39636636
PMCPMC11621987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.